Diversified Trust Co lowered its position in monday.com Ltd. (NASDAQ:MNDY – Free Report) by 29.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,620 shares of the company’s stock after selling 1,924 shares during the quarter. Diversified Trust Co’s holdings in monday.com were worth $1,044,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also bought and sold shares of the business. 1832 Asset Management L.P. boosted its stake in shares of monday.com by 12.1% in the 4th quarter. 1832 Asset Management L.P. now owns 860,300 shares of the company’s stock valued at $161,573,000 after purchasing an additional 92,600 shares in the last quarter. Jennison Associates LLC purchased a new stake in monday.com during the fourth quarter valued at about $131,086,000. Polar Capital Holdings Plc grew its stake in shares of monday.com by 53.0% during the third quarter. Polar Capital Holdings Plc now owns 431,738 shares of the company’s stock valued at $68,741,000 after buying an additional 149,587 shares during the last quarter. Eventide Asset Management LLC increased its holdings in shares of monday.com by 100.3% in the fourth quarter. Eventide Asset Management LLC now owns 407,870 shares of the company’s stock worth $76,602,000 after buying an additional 204,253 shares during the period. Finally, Goldman Sachs Group Inc. lifted its stake in shares of monday.com by 23.3% in the 4th quarter. Goldman Sachs Group Inc. now owns 351,518 shares of the company’s stock valued at $66,019,000 after acquiring an additional 66,471 shares during the last quarter. 73.70% of the stock is currently owned by institutional investors.
monday.com Price Performance
Shares of NASDAQ MNDY opened at $239.97 on Tuesday. monday.com Ltd. has a 1 year low of $122.13 and a 1 year high of $249.00. The firm has a 50-day moving average of $215.75 and a 200 day moving average of $210.35. The stock has a market cap of $11.59 billion, a P/E ratio of 631.52, a price-to-earnings-growth ratio of 48.15 and a beta of 1.30.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on MNDY. Oppenheimer raised their price target on monday.com from $240.00 to $250.00 and gave the stock an “outperform” rating in a research report on Thursday, May 16th. The Goldman Sachs Group raised their target price on shares of monday.com from $270.00 to $300.00 and gave the stock a “buy” rating in a report on Thursday, May 16th. DA Davidson upped their price target on shares of monday.com from $190.00 to $230.00 and gave the company a “neutral” rating in a report on Thursday, May 16th. William Blair reissued an “outperform” rating on shares of monday.com in a report on Monday, June 24th. Finally, Wells Fargo & Company upped their price objective on shares of monday.com from $260.00 to $275.00 and gave the company an “overweight” rating in a research note on Thursday, May 16th. Three research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $253.82.
Get Our Latest Analysis on monday.com
monday.com Company Profile
monday.com Ltd., together with its subsidiaries, develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally. The company provides Work OS, a cloud-based visual work operating system that consists of modular building blocks used and assembled to create software applications and work management tools.
Read More
- Five stocks we like better than monday.com
- What is the Nikkei 225 index?
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for monday.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for monday.com and related companies with MarketBeat.com's FREE daily email newsletter.